Feng Y - Search Results

1

MicroRNA‑192 inhibits cell proliferation and induces apoptosis in human breast cancer by targeting caveolin 1.

Chen P, Feng Y, Zhang H, Shi X, Li B, Ju W, Yu X, Zhang N, Luo X. Chen P, et al. Among authors: feng y. Oncol Rep. 2019 Nov;42(5):1667-1676. doi: 10.3892/or.2019.7298. Epub 2019 Aug 30. Oncol Rep. 2019. PMID: 31485620 Free PMC article.

2

Knockdown of circDENND4C inhibits glycolysis, migration and invasion by up-regulating miR-200b/c in breast cancer under hypoxia.

Ren S, Liu J, Feng Y, Li Z, He L, Li L, Cao X, Wang Z, Zhang Y. Ren S, et al. Among authors: feng y. J Exp Clin Cancer Res. 2019 Sep 5;38(1):388. doi: 10.1186/s13046-019-1398-2. J Exp Clin Cancer Res. 2019. PMID: 31488193 Free PMC article.

3

Polymorphisms in the telomerase reverse transcriptase promoter are associated with risk of breast cancer: A meta-analysis.

Li ZY, Dong YL, Feng Y, Zhang Z, Cao XZ. Li ZY, et al. Among authors: feng y. J Cancer Res Ther. 2016 Apr-Jun;12(2):1040-4. doi: 10.4103/0973-1482.164701. J Cancer Res Ther. 2016. PMID: 27461695 Free article.

4

Antiproliferative and apoptotic activity of glycyrrhizinic acid in MCF-7 human breast cancer cells and evaluation of its effect on cell cycle, cell migration and m-TOR/PI3K/Akt signalling pathway.

Zhang Z, Feng Y, Li ZY, Cao XZ. Zhang Z, et al. Among authors: feng y. Arch Med Sci. 2019 Jan;15(1):174-182. doi: 10.5114/aoms.2018.79429. Epub 2018 Nov 8. Arch Med Sci. 2019. Retraction in: Arch Med Sci. 2023 Mar 16;19(2):555. doi: 10.5114/aoms/162278 PMID: 30697268 Free PMC article. Retracted.

5

TMPO-AS1 promotes cell proliferation of thyroid cancer via sponging miR-498 to modulate TMPO.

Li Z, Feng Y, Zhang Z, Cao X, Lu X. Li Z, et al. Among authors: feng y. Cancer Cell Int. 2020 Jul 8;20:294. doi: 10.1186/s12935-020-01334-4. eCollection 2020. Cancer Cell Int. 2020. PMID: 32669970 Free PMC article.

6

Preparation, Biocompatibility and Antitumor Activity of Nanodelivery System Targeting Breast Cancer Base on a Silica Nanoparticle.

Liu J, Ren S, Zhang X, Feng Y, Qiu Z, Ma L, Huang J. Liu J, et al. Among authors: feng y. Onco Targets Ther. 2021 May 25;14:3429-3442. doi: 10.2147/OTT.S291142. eCollection 2021. Onco Targets Ther. 2021. PMID: 34079288 Free PMC article.

7

[Expression of deleted in liver cancer 1 and phosphorelated focal adhesion kinase in breast cancer].

Feng Y, Zhou HX, Li JH, Li ZY, Cheng WG, Jin ML, He L. Feng Y, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2011 Aug;31(8):1448-51. Nan Fang Yi Ke Da Xue Xue Bao. 2011. PMID: 21868344 Chinese.

8

Platinum-based neoadjuvant chemotherapy for triple-negative breast cancer: a systematic review and meta-analysis.

Li ZY, Zhang Z, Cao XZ, Feng Y, Ren SS. Li ZY, et al. Among authors: feng y. J Int Med Res. 2020 Oct;48(10):300060520964340. doi: 10.1177/0300060520964340. J Int Med Res. 2020. PMID: 33100072 Free PMC article.

9

Retracted: Antiproliferative and apoptotic activity of glycyrrhizinic acid in MCF-7 human breast cancer cells and evaluation of its effect on cell cycle, cell migration and m-TOR/PI3K/Akt signalling pathway.

Zhang Z, Feng Y, Li ZY, Cao XZ. Zhang Z, et al. Among authors: feng y. Arch Med Sci. 2023 Mar 16;19(2):555. doi: 10.5114/aoms/162278. eCollection 2023. Arch Med Sci. 2023. PMID: 37034508 Free PMC article.

10

Plasminogen activator, urokinase enhances the migration, invasion, and proliferation of colorectal cancer cells by activating the Src/ERK pathway.

Ding Y, Niu W, Zheng X, Zhou C, Wang G, Feng Y, Yu B. Ding Y, et al. Among authors: feng y. J Gastrointest Oncol. 2022 Dec;13(6):3100-3111. doi: 10.21037/jgo-22-1215. J Gastrointest Oncol. 2022. PMID: 36636041 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26,638 results

Search Page

Filters